H3 Biomedicine Inc., a U.S.-based precision medicine research & development subsidiary of Eisai Co., Ltd., announced it will present four posters during the 2019 American Society of Clinical Oncology Annual Meeting, which will be held May 31 – June 4, 2019 in Chicago.
May 16, 2019
· 4 min read